Abstract
Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic.
Highlights
The coronavirus disease 2019 (COVID-19) pandemic is upon us
COVID-19 can cause severe disease requiring intensive care, extracorporeal membrane oxygenation (ECMO) could be of use in those unresponsive to conventional care. Providing complex therapies such as ECMO during outbreaks of emerging infectious diseases has unique challenges – we aim to review ECMO as a mechanical support option in COVID-19 patients with critical disease
ECMO has developed from being used as a ‘rescue therapy’ to become an accepted treatment option for patients with severe acute respiratory distress syndrome (ARDS)
Summary
The coronavirus disease 2019 (COVID-19) pandemic is upon us. We are learning and experiencing this viral tsunami with limited published data regarding management guidelines and patient outcomes. COVID-19 can cause severe disease requiring intensive care, extracorporeal membrane oxygenation (ECMO) could be of use in those unresponsive to conventional care. Providing complex therapies such as ECMO during outbreaks of emerging infectious diseases has unique challenges – we aim to review ECMO as a mechanical support option in COVID-19 patients with critical disease.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
